Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...

An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...

(IN BRIEF) An international team of researchers has made a significant breakthrough in Alzheimer’s drug development with the introduction of RI-AG03, a novel peptide inhibitor that targets and ...

Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader ...

As more neurons die, memory, thinking, and behavior become increasingly impaired, leading to the cognitive decline seen in Alzheimer's. There are two specific "hotspots" of the tau protein where ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...